BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sanz-Ortega L, Rojas JM, Barber DF. Improving Tumor Retention of Effector Cells in Adoptive Cell Transfer Therapies by Magnetic Targeting. Pharmaceutics 2020;12:E812. [PMID: 32867162 DOI: 10.3390/pharmaceutics12090812] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Knauer N, Pashkina E, Aktanova A, Boeva O, Arkhipova V, Barkovskaya M, Meschaninova M, Karpus A, Majoral JP, Kozlov V, Apartsin E. Effects of Cationic Dendrimers and Their Complexes with microRNAs on Immunocompetent Cells. Pharmaceutics 2022;15. [PMID: 36678776 DOI: 10.3390/pharmaceutics15010148] [Reference Citation Analysis]
2 Comanescu C. Magnetic Nanoparticles: Current Advances in Nanomedicine, Drug Delivery and MRI. Chemistry 2022;4:872-930. [DOI: 10.3390/chemistry4030063] [Reference Citation Analysis]
3 Chan MH, Huang WT, Satpathy A, Su TY, Hsiao M, Liu RS. Progress and Viewpoints of Multifunctional Composite Nanomaterials for Glioblastoma Theranostics. Pharmaceutics 2022;14:456. [PMID: 35214188 DOI: 10.3390/pharmaceutics14020456] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Ding Y, Hu Q. Stimuli-responsive drug delivery systems for cancer immunotherapy. Stimuli-Responsive Nanocarriers 2022. [DOI: 10.1016/b978-0-12-824456-2.00014-x] [Reference Citation Analysis]
5 Ferreras C, Fernández L, Clares-Villa L, Ibáñez-Navarro M, Martín-Cortázar C, Esteban-Rodríguez I, Saceda J, Pérez-Martínez A. Facing CAR T Cell Challenges on the Deadliest Paediatric Brain Tumours. Cells 2021;10:2940. [PMID: 34831165 DOI: 10.3390/cells10112940] [Reference Citation Analysis]
6 Loh JS, Tan LKS, Lee WL, Ming LC, How CW, Foo JB, Kifli N, Goh BH, Ong YS. Do Lipid-based Nanoparticles Hold Promise for Advancing the Clinical Translation of Anticancer Alkaloids? Cancers (Basel) 2021;13:5346. [PMID: 34771511 DOI: 10.3390/cancers13215346] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Egea-Benavente D, Ovejero JG, Morales MDP, Barber DF. Understanding MNPs Behaviour in Response to AMF in Biological Milieus and the Effects at the Cellular Level: Implications for a Rational Design That Drives Magnetic Hyperthermia Therapy toward Clinical Implementation. Cancers (Basel) 2021;13:4583. [PMID: 34572810 DOI: 10.3390/cancers13184583] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
8 Boosz P, Pfister F, Stein R, Friedrich B, Fester L, Band J, Mühlberger M, Schreiber E, Lyer S, Dudziak D, Alexiou C, Janko C. Citrate-Coated Superparamagnetic Iron Oxide Nanoparticles Enable a Stable Non-Spilling Loading of T Cells and Their Magnetic Accumulation. Cancers (Basel) 2021;13:4143. [PMID: 34439296 DOI: 10.3390/cancers13164143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Li Y, Wei X, Tao F, Deng C, Lv C, Chen C, Cheng Y. The potential application of nanomaterials for ferroptosis-based cancer therapy. Biomed Mater 2021;16. [PMID: 34038885 DOI: 10.1088/1748-605X/ac058a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
10 Zheng C, Zhang J, Chan HF, Hu H, Lv S, Na N, Tao Y, Li M. Engineering Nano‐Therapeutics to Boost Adoptive Cell Therapy for Cancer Treatment. Small Methods 2021;5:2001191. [DOI: 10.1002/smtd.202001191] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]